D Capdevielle
Overview
Explore the profile of D Capdevielle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
429
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Godin O, Pignon B, Szoke A, Boyer L, Aouizerate B, Schorr B, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2022 Sep;
120:110641.
PMID: 36122839
Aims: Metabolic Syndrome (MetS) is a major health epidemic of Western countries and patients with schizophrenia is a particularly vulnerable population due to lifestyle, mental illness and treatment factors. However,...
2.
Garosi A, Sunhary de Verville P, Etchecopar-Etchart D, Richieri R, Godin O, Schurhoff F, et al.
Eur Arch Psychiatry Clin Neurosci
. 2022 Jul;
273(4):825-837.
PMID: 35852617
Parent history of severe mental illness (PHSMI) may have long-term consequences in adult offspring due to genetic and early environmental factors in preliminary studies. To compare the outcomes associated in...
3.
Fond G, Dubreucq J, Sunhary de Verville P, Godin O, Andrieu-Haller C, Berna F, et al.
Eur Arch Psychiatry Clin Neurosci
. 2022 Mar;
272(7):1379-1384.
PMID: 35333961
Among severe psychiatric disorders, schizophrenia has one of the highest impacts on professional and personal functioning with important indirect costs including disability pension allowance for the patients with the more...
4.
Schandrin A, Picot M, Marin G, Andre M, Gardes J, Leger A, et al.
Schizophr Res
. 2022 Jan;
240:103-112.
PMID: 34991040
Background: Lack of insight is a barrier to treating psychosis. Preliminary studies have suggested that showing people videos of their psychotic behaviour may improve personal insight. This clinical trial aimed...
5.
Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohort
Fond G, Sunhary de Verville P, Richieri R, Etchecopar-Etchart D, Korchia T, Faugere M, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2021 May;
111:110335.
PMID: 33933539
Background: Peripheral inflammation is associated with impaired prognosis in schizophrenia (SZ). Highly sensitive C-reactive protein (hs-CRP) is the most used inflammatory biomarker in daily practice. However, no consensual cut-off has...
6.
Sunhary de Verville P, Etchecopar-Etchart D, Richieri R, Godin O, Schurhoff F, Berna F, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2021 Feb;
110:110275.
PMID: 33582207
Background: Sleep disorders associated factors are under explored in schizophrenia while the literature suggests high and heterogeneous frequency. Aims: The objective of the present study was to determine the prevalence...
7.
Fond G, Korchia T, Sunhary de Verville P, Godin O, Schurhoff F, Berna F, et al.
J Affect Disord
. 2020 Jul;
274:617-623.
PMID: 32663995
Background: Impaired Quality of life (QoL) in schizophrenia has been mostly associated with psychotic and mood symptomatology, insight and functioning so far. Aims: QoL levels remain unsatisfactory due to other...
8.
Fond G, Godin O, Schurhoff F, Berna F, Andre M, Aouizerate B, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2020 Mar;
101:109927.
PMID: 32173456
Background: The National FondaMental Centers of Expertise (FACE) for Schizophrenia (SZ) have been created to shorten the gap between research and clinical practice. Objectives: To synthetize in a review the...
9.
Fond G, Godin O, Dumontaud M, Faget C, Schurhoff F, Berna F, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2019 May;
94:109654.
PMID: 31125587
Background: Sexual dysfunctions (SD) are frequent in schizophrenia (SZ) and associated with treatment withdrawal, however they remain under-explored and under-treated. To date, most of the studies have focused on SD...
10.
Dubreucq J, Ycart B, Gabayet F, Perier C, Hamon A, Llorca P, et al.
Eur Arch Psychiatry Clin Neurosci
. 2019 Apr;
269(5):599-610.
PMID: 30963264
Psychosocial Interventions (PIs) have shown positive effects on clinical and functional outcomes of schizophrenia (SZ) in randomized controlled trials. However their effectiveness and accessibility remain unclear to date in "real...